We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fast and Accurate Diagnostic Test Introduced for Meningitis

By LabMedica International staff writers
Posted on 12 May 2009
A novel, fast-acting multiplex polymerase chain reaction (PCR) diagnostic technique simultaneously verifies a complex range of pathogens that indicate meningitis, a severely debilitating infection that if not diagnosed and treated quickly can result in death.

The Seeplex meningitis ACE detection tests for 12 meningitis-causing pathogens: five bacteria--Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, Listeria monocytogenes, and Streptococcus agalactiae; and seven viruses-- Herpes simplex virus 1 and 2 (HSV1, HSV2), varicella zoster virus (VZV, or human herpesvirus 3), Epstein-Bar virus (EBV, or human herpesvirus 4), Cytomegalovirus (CMV), human herpesvirus 6 (HHV6), and enteroviruses from cerebrospinal fluid (CSF).

Traditional methods of diagnosing meningitis rely on culture and Gram staining, both of which have notable performance limitations that can result in inaccurate diagnosis of meningitis. More...
Culture of CSF takes more than three days to obtain test results that can be unclear because of recent antibiotic use, contamination, or fastidious bacteria.

Gram staining is one of the oldest microbiologic tests that distinguish between Gram-positive and Gram-negative bacteria. But Gram staining does not identify the individual strain of bacteria. This type of detailed information is necessary for applying the correct antibiotics that can destroy certain meningitis causing bacteria, and prevent its spread to other people.

The World Health Organization (WHO; Geneva, Switzerland) estimates that 1.2 million cases of bacterial meningitis occur every year around the world, out of which 135,000 are fatal. The WHO postulates that a significant number of viral meningitis infections go undiagnosed in the absence of a standard diagnostic tool to determine the infections.

Seeplex technology is provided by Seegene (Seoul, Korea), a biotechnology company specialized in molecular diagnostics and research applications. "Seeplex Meningitis ACE detection provides accurate, rapid and cost-effective meningitis diagnostics. The test is a clear break from traditional methods of diagnosing meningitis, taking only six hours to detect either bacterial or viral meningitis infection in an easy to use testing format," said Dr. Jong-Yoon Chun, founder and CEO of Seegene. "This test will help to save lives and prevent unnecessary antibiotic prescriptions by providing precise information of meningitis causing pathogens at the earliest possible stage."

Related Links:

World Health Organization
Seegene



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Test Reader
DIA5000
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more

Microbiology

view channel
Image: MycoMEIA Aspergillus Assay is the first FDA-cleared urine-based test for invasive aspergillosis (Photo courtesy of Pearl Diagnostics)

Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People

Invasive Aspergillosis (IA), a life-threatening fungal infection, poses a serious threat to immunocompromised individuals, especially those with hematologic malignancies, transplants, or severe lung diseases.... Read more

Industry

view channel
Image: The acquisition of Exosome Diagnostics adds the ExoDx Prostate test to Mdxhealth’s portfolio (Photo courtesy of Bio-Techne)

Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has entered into an agreement with Mdxhealth SA (Irvine, CA, USA), which will acquire its Exosome Diagnostics Inc. (Waltham, MA, US) business, including the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.